Literature DB >> 2199635

Iron deficiency: improved exercise performance within 15 hours of iron treatment in rats.

W T Willis1, K Gohil, G A Brooks, P R Dallman.   

Abstract

We tested the hypothesis that a very rapid improvement in exercise performance of iron-deficient rats after treatment with iron might reveal a rate-limiting role of ionic iron as an enzyme cofactor in energy metabolism. Rats were given iron-deficient or control diets after weaning at 21 d of age and intraperitoneal iron dextran (50 mg/kg) at 45 d of age. Time to fatigue during an easy walking exercise (endurance) was measured 15 and 18 h after iron dextran or saline injection. Endurance increased more than threefold compared to the saline-treated, iron-deficient animals without a significant change in hemoglobin concentration. This prompt improvement suggests that lack of cofactor iron might play a metabolically important role in impairing exercise performance in the severely iron-deficient rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199635     DOI: 10.1093/jn/120.8.909

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  8 in total

1.  Cardioprotection by Hepc1 in cTnT(R141W) transgenic mice.

Authors:  Li Zhang; Dan Lu; Wei Zhang; Xiongzhi Quan; Wei Dong; Yanfeng Xu; Lianfeng Zhang
Journal:  Transgenic Res       Date:  2011-12-24       Impact factor: 2.788

Review 2.  Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.

Authors:  Qurat-ul-ain Jelani; Stuart D Katz
Journal:  Cardiol Rev       Date:  2010 Sep-Oct       Impact factor: 2.644

Review 3.  Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency.

Authors:  Iain C Macdougall; Bernard Canaud; Angel L M de Francisco; Gerasimos Filippatos; Piotr Ponikowski; Donald Silverberg; Dirk J van Veldhuisen; Stefan D Anker
Journal:  Eur J Heart Fail       Date:  2012-04-20       Impact factor: 15.534

4.  Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study.

Authors:  Sigismond Lasocki; Nicolas Chudeau; Thibaut Papet; Deborah Tartiere; Antoine Roquilly; Laurence Carlier; Olivier Mimoz; Philippe Seguin; Yannick Malledant; Karim Asehnoune; Jean François Hamel
Journal:  Crit Care       Date:  2014-09-30       Impact factor: 9.097

Review 5.  Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?

Authors:  Theresa McDonagh; Iain C Macdougall
Journal:  Eur J Heart Fail       Date:  2015-01-30       Impact factor: 15.534

Review 6.  Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure?

Authors:  Nicole Ebner; Stephan von Haehling
Journal:  Card Fail Rev       Date:  2019-11-04

Review 7.  Iron deficiency in heart failure: a practical guide.

Authors:  Nicole Ebner; Stephan von Haehling
Journal:  Nutrients       Date:  2013-09-23       Impact factor: 5.717

8.  The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.

Authors:  Victor E Pollak; Jonathan A Lorch; Rakesh Shukla; Supriya Satwah
Journal:  BMC Nephrol       Date:  2009-02-26       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.